[
Bagchi, R. A., Weeks, K. L. (2019). Histone deacetylases in cardiovascular and metabolic diseases. J. Mol. Cell. Cardiol., 130, 151–159.
]Search in Google Scholar
[
Buraka, E., Chen, C. Y., Gavare, M., Grube, M., Makarenkova, G., Nikolajeva, V., Bisenieks, I., Brūvere, I., Bisenieks, E., Duburs, G., Sjakste, N. (2014). DNA-binding studies of AV-153, an antimutagenic and DNA repair-stimulating derivative of 1,4-dihydropiridine. Chem. Biol. Interact., 220, 200–207.
]Search in Google Scholar
[
Chanda, D., Luiken, J. J. F. P., Glatz, J. F. C. (2016). Signalling pathways involved in cardiac energy metabolism. FEBS Lett., 590 (15), 2364–2374.
]Search in Google Scholar
[
Chen, Y., Du, J., Zhao, Y. T., Zhang, L., Lv, G., Zhuang, S., Qin, G., Zhao, T. C. (2015). Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice. Cardiovasc. Diabetol., 14, 99.
]Search in Google Scholar
[
Choi, S. Y., Jeong, H. J., Lim, H. G., Park, S. S., Kim, S. H., Kim, Y. J. (2012). Elimination of alpha-galxenoreactive epitope: alpha-galactosidase treatment of porcine heart valves. J. Heart. Valve Dis., 21, 387–397.
]Search in Google Scholar
[
Dislere, K., Rostoka, E., Bisenieks, E., Duburs, G., Paramonova, N., Sjakste, N. (2021). 1,4-dihydropyridine derivatives increase mRNA expression of Psma3, Psmb5, and Psmc6 in rats. Arh. Hig. Rada Toksikol. 72, 148–156.
]Search in Google Scholar
[
Faramoushi, M., Sasan, R. A., Sarraf, V. S., Karimi, P. (2016). Cardiac fibrosis and down regulation of GLUT4 in experimental diabetic cardiomyopathy are ameliorated by chronic exposures to intermittent altitude. J. Cardiovasc. Thorac. Res., 8 (1), 26–33.
]Search in Google Scholar
[
Faria, A., Persaud, S. J. (2017). Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential. Pharmacol. Ther., 172, 50–62.
]Search in Google Scholar
[
Forbes, J. M., Cooper, M. E. (2013). Mechanisms of diabetic complications. Physiol. Rev., 93, 137–188.
]Search in Google Scholar
[
Gilca, G.E., Stefanescu, G., Badulescu, O., Tanase, D. M., Bararu, I., Ciocoiu, M. (2017). Diabetic cardiomyopathy: Current approach and potential diagnostic and therapeutic targets. J. Diabetes. Res., 2017, 1310265.
]Search in Google Scholar
[
Henning, R. J., Bourgeois, M., Harbison, R. D. (2018). Poly(ADP-ribose) polymerase (PARP) and PARP inhibitors: Mechanisms of action and role in cardiovascular disorders. Cardiovasc. Toxicol., 18, 493–506.
]Search in Google Scholar
[
Isfort, M., Stevens, S. C. W., Schaffer, S., Jong, C. J., Wold, L. E. (2014). Metabolic dysfunction in diabetic cardiomyopathy. Heart. Fail. Rev., 19, 35–48.
]Search in Google Scholar
[
Ivanović-Matić, S., Bogojević, D., Martinović, V., Petrović, A., Jovanović-Stojanov, S., Poznanović, G., Grigorov, I. (2014). Catalase inhibition in diabetic rats potentiates DNA damage and apoptotic cell death setting the stage for cardiomyopathy. J. Physiol. Biochem., 70 (4), 947–959.
]Search in Google Scholar
[
Khullar, M., Cheema, B. S., Raut, S. K. (2017). Emerging evidence of epigenetic modifications in vascular complication of diabetes. Front. Endocrinol. (Lausanne), 8, 237.
]Search in Google Scholar
[
Leonova, E., Ošiņa, K., Duburs, G., Bisenieks, E., Germini, D., Vassetzky, Y., Sjakste, N. (2019). Metal ions modify DNA-protecting and mutagen-scavenging capacities of the AV-153 1,4-dihydropyridine. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 845, 403077.
]Search in Google Scholar
[
Leonova, E., Rostoka, E., Sauvaigo, S., Baumane. L., Selga, T., Sjakste, N. (2018). Study of interaction of antimutagenic 1,4-dihydropyridine AV-153-Na with DNA-damaging molecules and its impact on DNA repair activity. PeerJ., 6, e4609.
]Search in Google Scholar
[
Leonova, E., Shvirksts, K., Borisovs, V., Smelovs, E., Sokolovska, J., Bisenieks, E., Duburs, G., Grube, M., Sjakste, N. (2020). Spectroscopic and electrochemical study of interactions between DNA and different salts of 1,4-dihydropyridine AV-153. PeerJ, 8, e10061.
]Search in Google Scholar
[
Maack, C., Lehrke, M., Backs, J., Heinzel, F. R., Hulot, J. S., Marx, N., Paulus, W. J., Rossignol, P., Taegtmeyer, H., et al. (2018). Heart failure and diabetes: Metabolic alterations and therapeutic interventions: A state-of-the-art review from the translational research committee of the heart failure association-European society of cardiology. Eur. Heart. J., 39 (48), 4243–4254.
]Search in Google Scholar
[
Maria, Z., Campolo, A. R., Scherlag, B. J., Ritchey, J. W., Lacombe, V. A. (2018). Dysregulation of insulin-sensitive glucose transporters during insulin resistance-induced atrial fibrillation. Biochim. Biophys. Acta. Mol. Basis. Dis., 1864 (4 Pt A), 987–996.
]Search in Google Scholar
[
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., Zuniga, F. A. (2018). Association between insulin resistance and the development of cardiovascular disease. Cardiovasc. Diabetol., 17 (1), 122.
]Search in Google Scholar
[
Osina, K., Leonova, E., Isajevs, S., Baumane, L., Rostoka, E., Sjakste, T., Bisenieks, E., Duburs, G., Vigante, B., Sjakste, N. (2017). Modifications of expression of genes and proteins involved in DNA repair and nitric oxide metabolism by carbatonides [disodium-2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) derivatives] in intact and diabetic rats. Arh. Hig. Rada Toksikol. 68, 212–227.
]Search in Google Scholar
[
Osina, K., Rostoka, E., Isajevs, S., Sokolovska, J., Sjakste, T., Sjakste, N. (2016). Effects of an antimutagenic 1,4-dihydropyridine AV-153 on expression of nitric oxide synthases and DNA repair-related enzymes and genes in kidneys of rats with a streptozotocin model of dabetes mellitus. Basic. Clin. Pharmacol. Toxicol., 119 (5), 458–463.
]Search in Google Scholar
[
Ošiņa, K., Rostoka, E., Sokolovska, J., Paramonova, N., Bisenieks, E., Duburs, G., Sjakste, N., Sjakste, T. (2016). 1,4-Dihydropyridine derivatives without Ca2+-antagonist activity up-regulate Psma6 mRNA expression in kidneys of intact and diabetic rats. Cell Biochem. Funct. 34, 3–6.
]Search in Google Scholar
[
Pepin, M. E., Wende, A. R. (2019). Epigenetics in the development of diabetic cardiomyopathy. Epigenomics., 11 (5), 469–472.
]Search in Google Scholar
[
Qin, W. D., Liu, G. L., Wang, J., Wang, H., Zhang, J. N., Zhang, F., Ma, Y., Ji, X. Y., Li, C., Zhang, M. X. (2016). Poly (ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy. Oncotarget, 7 (24), 35618–35631.
]Search in Google Scholar
[
Ryabokon, N. I., Goncharova, R. I., Duburs, G., Hancock, R., Rzeszowska-Wolny, J. (2008). Changes in poly(ADP-ribose) level modulate the kinetics of DNA strand break rejoining. Mutat. Res., 637, 173–181.
]Search in Google Scholar
[
Ryabokon, N. I., Goncharova, R. I., Duburs, G., Rzeszowska-Wolny, J. (2005). A 1,4-dihydropyridine derivative reduces DNA damage and stimulates DNA repair in human cells in vitro. Mutat Res., 587 (1–2), 52–58.
]Search in Google Scholar
[
Ryabokon, N. I., Nikitchenko, N. V., Dalivelya, O. V., Goncharova, R. I., Duburs, G., Konopacka, M., Rzeszowska-Wolny, J. (2009). Modulation of cellular defense processes in human lymphocytes in vitro by a 1,4-dihydropyridine derivative. Mutat. Res., 679 (1–2), 33–38.
]Search in Google Scholar
[
Szablewski, L. (2017). Glucose transporters in healthy heart and in cardiac disease. Int J. Cardiol., 230, 70–75.
]Search in Google Scholar
[
Varga, Z. V., Giricz, Z., Liaudet, L., Hasko, G., Ferdinandy, P., Pacher, P. (2015). Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim. Biophys. Acta, 1852 (2), 232–242.
]Search in Google Scholar
[
von Lukowicz, T., Hassa, P. O., Lohmann, C., Borén, J., Braunersreuther, V., Mach, F., Odermatt, B., Gersbach, M., Camici, G. G., Stähli, B. E., et al. (2008). PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovasc. Res. 78, 158–166.
]Search in Google Scholar
[
Waldman, M., Nudelman, V., Shainberg, A., Abraham, N. G., Kornwoski, R., Aravot, D., Arad, M., Hochhauser, E. (2018). PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis. Exp. Cell. Res., 373 (1–2), 112–118.
]Search in Google Scholar
[
Wang, J., Wang, S., Wang, J., Xiao, M., Guo, Y., Tang, Y., Zhang, J., Gu, J. (2021). Epigenetic regulation associated with sirtuin 1 in complications of diabetes mellitus. Frontiers Endocrinol., 11, 598012.
]Search in Google Scholar
